ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $22,000 | -87.4% | 23,923 | -72.1% | 0.00% | -60.0% |
| Q4 2019 | $174,000 | +40.3% | 85,784 | +97.0% | 0.01% | -28.6% |
| Q3 2019 | $124,000 | -88.0% | 43,545 | -67.8% | 0.01% | -82.5% |
| Q2 2019 | $1,037,000 | +60.0% | 135,239 | +177.1% | 0.04% | +8.1% |
| Q1 2019 | $648,000 | +239.3% | 48,800 | +296.7% | 0.04% | +270.0% |
| Q4 2018 | $191,000 | -89.9% | 12,300 | -81.4% | 0.01% | -74.4% |
| Q2 2018 | $1,899,000 | +300.6% | 66,200 | +192.9% | 0.04% | +457.1% |
| Q1 2017 | $474,000 | -38.2% | 22,600 | -44.6% | 0.01% | -63.2% |
| Q4 2016 | $767,000 | +159.1% | 40,800 | +358.4% | 0.02% | -57.8% |
| Q2 2015 | $296,000 | +1.4% | 8,900 | +1.1% | 0.04% | +60.7% |
| Q1 2015 | $292,000 | – | 8,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |